A sperm cell is mostly a delivery vehicle with a motor bolted to it. The midpiece, the section just behind the head, is packed with mitochondria, and those mitochondria have to generate enough ATP to drive the tail for the entire journey. Coenzyme Q10 sits inside the mitochondrial membrane as part of the electron transport chain. No CoQ10, no ATP. No ATP, no movement.
That is why CoQ10 keeps appearing in male fertility research while most supplement ingredients marketed for fertility do not. There is a specific, physically obvious reason to expect it to matter for sperm motility, and researchers have spent two decades testing whether it does.
The answer, as of the two systematic reviews published in 2025, is more encouraging than the answer for most supplements. It is also narrower than most product pages will tell you.
What the pooled trial data shows
Two meta-analyses published in 2025 are the current best summary.
The first pooled eight randomised controlled trials covering 877 men, 462 taking CoQ10 and 415 in control groups. Total sperm counts, total and progressive motility, and the proportion of normally formed sperm all came out higher in the CoQ10 groups, each reaching statistical significance. Serum testosterone and inhibin B, a hormone produced by Sertoli cells that tracks how well the testes are producing sperm, were also higher.
The second looked specifically at idiopathic male infertility, meaning cases where standard workup finds no identifiable cause. It pooled nine studies with 781 participants and found significant improvements in sperm concentration, seminal volume and total motility. Two findings inside it matter more than the headline. Improvement in sperm morphology only reached significance when treatment ran beyond three months. And clinical pregnancy rates improved, again mainly in the trials that ran longer than three months.
That last point deserves emphasis because it is rare. Most supplement research stops at surrogate markers and never measures whether anything happens to the outcome people actually want. Here, some trials did measure pregnancy, and the signal was positive.
An earlier meta-analysis of double-blind placebo-controlled trials found the same direction on concentration and motility, and added a detail worth knowing: men with lower baseline motility had a measurably higher probability of responding to treatment. CoQ10 appears to do more for men whose numbers are already poor than for men whose numbers are fine.
Why 35 shows up in this conversation
Male fertility does not have a cliff the way female fertility does, which is where a lot of confusion starts. What it has is a slow slide that begins earlier than most men expect.
Sperm volume, total count, motility and morphology start declining around the mid-thirties, with the sharpest drop in motility and progressive motility appearing after 35 and becoming more pronounced past 40. The change that matters most, though, is not the count. It is DNA integrity.
Sperm DNA fragmentation index rises with paternal age. In one comparison, men over 40 showed sperm DNA damage around 24 percent, against roughly 17 percent in men under 30. Most researchers reviewing this literature place the clinically meaningful threshold nearer 40 than 35. The mechanism is a compounding one: ageing sperm package their chromatin less tightly, repair DNA strand breaks less effectively, and sit in an environment with more oxidative stress, so damage accumulates while the ability to fix it declines.
This is where the CoQ10 rationale gets specific rather than generic. CoQ10 is an antioxidant as well as an electron carrier, and seminal oxidative stress is one of the main drivers of DNA fragmentation. A trial in men with idiopathic oligoasthenozoospermia found CoQ10 improved sperm parameters and antioxidant status while reducing both total reactive oxygen species and DNA fragmentation compared to their pretreatment values.
So the honest framing of "after 35" is not that a switch flips at your 35th birthday. It is that the oxidative and DNA-integrity problems CoQ10 plausibly addresses are the same problems that intensify with age.
The Indian picture
Male infertility is badly under-discussed in India relative to how common it is, and the numbers explain why that silence is a problem.
Estimates for how much of Indian couple infertility is attributable to male factor vary widely by source. ICMR figures are commonly cited in the 10 to 15 percent band, while various clinical estimates run considerably higher. The variation itself tells you something about how inconsistently male factor gets evaluated. What is less disputed is the trend: analyses of Indian semen data over recent decades show a consistent time-related decline in sperm count, motility and morphology, and a south Indian retrospective study documented the same deterioration among men presenting at fertility clinics.
The drivers named in this literature are the ones we write about constantly for other reasons: obesity, diabetes and metabolic syndrome, alongside environmental exposure, chronic stress and later parenthood. Metabolic dysfunction is not a separate problem from fertility. It is upstream of it.
That overlap matters for anyone reading this as a supplement question. If you carry visceral fat at a normal body weight, which is the pattern we cover in why Indians are more prone to insulin resistance, your metabolic health is doing more to your sperm parameters than any capsule will undo. The same applies to oxidative load; the practical ways to reduce chronic inflammation address the environment sperm develop in, not just a lab marker.
Dose, form and how long it takes
The trials that produced results clustered around a narrow set of conditions, and this is the part product marketing tends to blur.
Dose. The trials that worked used 200 to 400 mg daily. A 2012 double-blind placebo-controlled trial in 228 men used 200 mg of ubiquinol and found improvements in sperm density, motility and morphology. A 2019 trial comparing two doses head to head found greater gains at 400 mg than at 200 mg. At 200 mg daily, seminal plasma CoQ10 rose roughly three-fold and levels inside sperm cells roughly two-fold, which confirms that oral dosing actually reaches the tissue in question.
Duration. Spermatogenesis takes about 74 days. Any trial shorter than that is measuring sperm that were already well into development before supplementation started. This is why the three-month threshold keeps appearing in the pooled data, and why morphology and pregnancy improvements showed up mainly in longer trials. Three months is the floor. Six is common in protocols.
Form. Absorption is the practical constraint with CoQ10 generally, and it is fat-soluble, so it needs to be taken with a meal containing fat. We have covered the ubiquinone and ubiquinol absorption question and what actually improves uptake in more detail, along with when in the day to take it, which comes down to the same fat-solubility issue.
The Oak Age formulation built around this ingredient is CoQ10 for heart and mitochondrial support, using CavaQ10 material, and it also appears alongside NMN and berberine in our Longevity Core combination. Whichever product anyone chooses, ours or another, the label needs to state milligrams per serving. A product that will not tell you the dose cannot be compared against trials that were run at 200 and 400 mg.
Safety and where this fits
Across the trial literature CoQ10 has been well tolerated, with no adverse effects reported in most studies and only mild, transient effects elsewhere, whether taken alone or alongside other antioxidants.
The interaction worth knowing is with warfarin, since CoQ10 is structurally similar to vitamin K and may reduce its anticoagulant effect. Anyone on warfarin should raise it with their doctor before starting. CoQ10 may also have a mild blood-pressure-lowering effect, relevant if you already take antihypertensives.
Both of those matter less than something simpler. A semen analysis costs very little in India and tells you whether there is anything to address in the first place. Supplementing blind, without knowing your baseline count, motility, morphology and ideally DNA fragmentation index, means you will not know whether anything changed. The pooled data says responders tend to be men with poor baseline motility. You cannot know if you are one of them without the test.
If conception has not happened after a year of trying, or six months if your partner is over 35, that is a fertility specialist conversation, not a supplement conversation. CoQ10 has reasonable evidence as an adjunct. It is not a treatment for the causes a workup would find, and delaying that workup is the expensive mistake.
What the evidence supports
Pooled randomised trial data shows CoQ10 improves sperm concentration, total and progressive motility, and morphology, with the morphology and clinical pregnancy signals emerging mainly past three months of use. Men with poorer baseline motility respond more. Doses of 200 to 400 mg daily measurably raise CoQ10 levels in seminal plasma and in sperm cells, and reduce markers of oxidative stress and DNA fragmentation.
What the evidence does not support is treating it as a fix for age. It does not reverse the DNA fragmentation that accumulates with paternal age, and the trials were run largely in men with diagnosed abnormal parameters, not in healthy men hoping to do better than normal. For a man over 35 in India, the sequence with evidence behind it starts with a semen analysis and honest attention to metabolic health, with CoQ10 as a reasonable adjunct on top of that rather than a substitute for it.
Citations
Alahmar, Ahmed T., et al. "Coenzyme Q10 Improves Sperm Parameters, Oxidative Stress Markers and Sperm DNA Fragmentation in Infertile Patients with Idiopathic Oligoasthenozoospermia." World Journal of Men's Health, 2020. PubMed, pubmed.ncbi.nlm.nih.gov/32009311/.
"Does Coenzyme Q10 Improve Semen Quality and Circulating Testosterone Level? A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Frontiers in Pharmacology, 2025. PMC, www.ncbi.nlm.nih.gov/pmc/articles/PMC11739123/.
"Efficacy and Safety of Coenzyme Q10 in Idiopathic Male Infertility: A Systematic Review and Meta-Analysis of Randomized Trials." World Journal of Men's Health, 2025, wjmh.org/DOIx.php?id=10.5534%2Fwjmh.250159.
Lafuente, Rafael, et al. "Coenzyme Q10 and Male Infertility: A Meta-Analysis." Journal of Assisted Reproduction and Genetics, 2013. PMC, www.ncbi.nlm.nih.gov/pmc/articles/PMC3800531/.
Safarinejad, Mohammad Reza, et al. "Effects of the Reduced Form of Coenzyme Q10 (Ubiquinol) on Semen Parameters in Men with Idiopathic Infertility: A Double-Blind, Placebo Controlled, Randomized Study." The Journal of Urology, vol. 188, no. 2, 2012, pp. 526-531. PubMed, pubmed.ncbi.nlm.nih.gov/22704112/.
Alahmar, Ahmed T. "The Impact of Two Doses of Coenzyme Q10 on Semen Parameters and Antioxidant Status in Men with Idiopathic Oligoasthenoteratozoospermia." Clinical and Experimental Reproductive Medicine, vol. 46, no. 3, 2019. PubMed, pubmed.ncbi.nlm.nih.gov/31408928/.
"Advanced Paternal Age and Sperm DNA Fragmentation: A Systematic Review." World Journal of Men's Health, 2021. PubMed, pubmed.ncbi.nlm.nih.gov/33987998/.
Das, Manidip, et al. "Effect of Advancing Paternal Age on Semen Parameters and Seminal Oxidative Stress Markers in Infertile Men." PMC, www.ncbi.nlm.nih.gov/pmc/articles/PMC4075617/.
"Infertile Men Older than 40 Years Are at Higher Risk of Sperm DNA Damage." Reproductive Biology and Endocrinology. PMC, www.ncbi.nlm.nih.gov/pmc/articles/PMC4258051/.
Mishra, Pallav, et al. "Decline in Seminal Quality in Indian Men over the Last 37 Years." Reproductive Biology and Endocrinology, 2018. PMC, www.ncbi.nlm.nih.gov/pmc/articles/PMC6199708/.
Adiga, Satish Kumar, et al. "Declining Semen Quality among South Indian Infertile Men: A Retrospective Study." Journal of Human Reproductive Sciences, 2008. PMC, www.ncbi.nlm.nih.gov/pmc/articles/PMC2700673/.
Disclaimer
The information on this page is for educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before making changes to your supplement routine. Statements on this page have not been evaluated by the Food Safety and Standards Authority of India (FSSAI).
